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Children with sickle cell disease (SCD) have significantly increased risk of invasive pneumococcal disease. In
this issue ofCell Host &Microbe, Carter et al. (2014) report that pneumococcal strains fromSCD children have
genetic mutations associated with the unique SCD environment, which need to be considered in developing
new vaccines.Streptococcus pneumoniae (the pneu-
mococcus) colonizes the nasopharynx of
humans and in some circumstances can
cause invasive diseases such as pneu-
monia, meningitis, and bacteraemia. This
organism is genetically variable and can
exchange DNA by the process of genetic
recombination with the occurrence of
more than 90 different serotypes, reflect-
ing the ability of the organism to exchange
capsular gene loci. Selective pressures
on the pneumococcal population, such
as use of antibiotics and vaccines, drive
the emergence of genetic variants with
altered capsule type or antibiotic targets.
The pneumococcus is therefore highly
adaptable to its environment and can
change rapidly in response to interven-
tions. The use of clinical interventions is
known to have a marked effect on pneu-
mococcal population structure (Croucher
et al., 2011). It is also recognized that
even single-nucleotide polymorphisms
may have an effect on the ability of the
pneumococcus to cause disease. A single
nucleotide difference in the genomes of
pneumococci taken from the blood and
cerebrospinal fluid (CSF) of a patient
with meningitis altered the expression
of an ABC transporter. This mutation
changed the virulence of the organism inmouse models of disease and also its
ability to grow in different environments
in vivo (Croucher et al., 2013). Genetic
variation of bacterial pathogens is there-
fore an important facet of the dynamic
host pathogen interaction and of great
consequence for the rationale of design
of new vaccines and treatments for infec-
tious diseases. The host environment,
and the interventions used to prevent
or treat disease, drives genetic variation
of the pneumococcus. The host envi-
ronment can be very different in some
populations, and susceptibility to pneu-
mococcal infection is known to vary in
these populations.
Children with sickle cell disease (SCD)
are at extremely high risk of fatal pneu-
mococcal infection, having a 600-fold
increased risk of fatal invasive pneu-
mococcal disease (IPD) (Overturf, 1999).
The increased infection risk has been
related to functional asplenia and comple-
ment deficiency, but SCD patients also
have altered plasma levels of zinc, iron,
purines, amino acids, and carbohydrates
(Darghouth et al., 2011; Prasad et al.,
1976). Given the high susceptibility to
pneumococcal infection, children with
SCD are routinely immunized with pneu-
mococcal vaccines and administeredprophylactic antibiotics alongside. The
pneumococcus therefore encounters a
very different environment in the sickle
cell patient to that found in the general
population (GP) in terms of host meta-
bolism and exposure to interventions.
In this issue of Cell Host & Microbe,
Carter et al. (2014) analyze and compare
the genomic sequences of more than
320 pneumococcal strains isolated from
carriage and disease in the GP and in chil-
dren with SCD. This analysis reveals that
the different host environments encoun-
tered in SCD lead to specific pneu-
mococcal adaptations associated with
colonization or disease in the SCD host,
as depicted in Figure 1. The vaccines
used to prevent pneumococcal disease
protect against a limited number of sero-
types chosen based on their likelihood to
cause disease in humans. It is well known
that use of these vaccines drives a shift
away from these types and an increase
in prevalence of capsule types not
included in the vaccine (so-called non-
vaccine types, or NVTs). NVTs are
considered to be less able to cause dis-
ease in the GP. A shift toward NVTs was
observed when vaccines were used in
both SCD and GP. The invasive potential
of NVT isolates was examined in a mouse15, May 14, 2014 ª2014 Elsevier Inc. 521
Figure 1. Diagram IllustratingHowMicroevolution of the Pneumococcal GenomeAffects the
Epidemiology of Carriage andDisease Isolates between PresumedHealthy Individuals of the
General Population and Sickle Cell Disease Patients
S. pneumoniae of established genotypes colonize, and cause invasive disease, in the normal host, as
depicted left. In colonizing the sickle cell disease (SCD) host, various adaptive mutations have been
described by Carter et al. (2014). Comparative genome analysis indicates accumulation of more muta-
tional changes in strains isolated from pneumococcal disease in SCD patients. Some of these mutations
are detected in the same genes observed in genomes from SCD carriage such as PiaA, as shown in
Figure 5 of Carter et al. (2014), in this issue of Cell Host & Microbe.
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able virulence in normal mice but were
all highly virulent in SCD mice, confirming
that NVT strains selected by the vaccine
are more virulent in the SCD than WT
background.
Comparison of genome sequences and
gene content of historical and contempo-
rary pneumococcal strains showed that
about half of the strains had undergone
some gene loss in SCD and others had
undergone intragenic recombination to
produce mosaic genes. These genetic
events were preferentially observed in
the SCD population, suggesting that
they may confer some advantage in SCD
but are outcompeted in theGP. The differ-
ences were observed in four key groups
of genes responsible for penicillin resis-
tance, capsule biosynthesis, metabolic
pathways, andmetal ion uptake. Mutation
in genes for capsule biosynthesis and
antibiotic resistance are expected due to
the selective pressure of antibiotic ther-
apy and vaccination in SCD patients as
noted above.
The mutations in genes involved in
metal ion uptake suggest these mutations
are not only beneficial in the SCD host
environment but can only be tolerated
in this host environment, but not in the
normal host. In order to test this hypothe-
sis, a panel of mutant strains was tested in
a mouse model of SCD using Tn-seq,
which is a technique that allows thou-
sands of tagged, loss-of-functionmutants522 Cell Host & Microbe 15, May 14, 2014 ª2to be generated and then screened in
wild-type and SCD mice. If a particular
loss-of-function mutant is less able to
survive in the mouse, it will be repre-
sented in lower abundance when the
strains are recovered and quantified by
DNA sequencing of the identifying tag.
Sixty genes were shown to confer differ-
ential fitness between the two hosts, re-
flecting the different environments in WT
and SCD mice. The functions of genes
under selective pressure in SCD mice
correlate strongly with aspects of SCD
pathophysiology in humans, including
abnormal iron homeostasis, purine meta-
bolism, and complement function. Impor-
tantly, six of the genes identified to be
associated with SCD in the mouse model
were either altered or absent in clinical
isolates from human SCD patients,
showing the relevance of themouse study
to the clinical situation.
One of these six genes identified by
Tn-seq analysis in mice is involved in
iron transport into the pneumococcus.
The iron transport complex in the pneu-
mococcus is highly immunogenic, and
loss of this protein may be advantageous
in avoiding the immune response. It
seems that the iron transport process is
not required or is even detrimental to the
bacterium in the iron-rich SCD host. This
raises the general question about protec-
tive immunity in the SCD host. The ability
of the bacterium to thrive despite the
loss of antigenic proteins could compro-014 Elsevier Inc.mise protective immunity in specific host
environments. Loss of immunogenic pro-
teins is only possible if the function of
the protein is no longer required due to
the specific environment.
The principle that vaccine efficacy may
be compromised by the host environment
is demonstrated experimentally in this
study. The iron transporter protein (PiaA)
and the complement-degrading enzyme
(CppA) are potential targets for inclusion
in new protein-based vaccines against
pneumococcal diseases. Vaccination of
wild-type and SCD mice with these
proteins stimulated antibody responses.
Subsequent challenge of the animals
with Streptococcus pneumoniae showed
that WT animals were protected from
challenge by the vaccination but SCD
mice were not. This is presumably due
to lack of expression of PiaA in the high
iron environment and a lack of require-
ment for antibody-mediated neutraliza-
tion of CppA in the low-complement envi-
ronment of SCD. These are very important
observations in terms of vaccine design
and highlight the need to consider the
environment within the population tar-
geted for vaccination. This also raises
another issue for consideration when
refining the selection of vaccine targets,
that of gene expression. The prediction
arising from the work of Carter et al.
(2014) is that the different environment
within the SCD patient will have a marked
effect on bacterial gene expression
during infection, that is likely to be
different to that in the GP. Exposure to
high levels of iron in SCD patients, for
example, would be expected to alter the
pneumococcal transcriptome during IPD
in SCD patients. Some of the genomic
changes observed in strains from SCD
may also result in subsequent alteration
of gene expression.
The use ofwell-characterized strain col-
lections and high-throughput sequencing
is a powerful approach to understanding
the interaction of pathogen and host.
The importance of the microenvironment
within the host on pathogen variation in
patients with SCD is clearly demonstrated
in this study. Bacteria are adaptable and
are able to live in a whole range of environ-
ments. These include those encountered
by pathogens during infection. The study
by Carter et al. (2014) highlights how
different environments in various patient
cohorts can affect the bacterial population
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into account when planning vaccine or
intervention strategies. Several intriguing
questions remain regarding pneumo-
coccal carriage, transmission, and evolu-
tionary adaptation. Are carriage strains of
S. pneumoniae in SCD patients continu-
ously reseeded from strains carried by
the GP, or are these transmitted from
SCD patient to patient? If the latter is
true, this would mean that the pneumo-
coccus is undergoing parallel but sepa-
rate linear evolutionary pathways in thesetwo populations. The use of ‘‘designer’’
vaccines to target these populations
should be considered.REFERENCES
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The NOD-like receptors (NLRs) were among the first innate immune receptors discovered, yet a clear
understanding of the basic principles underlying their mechanisms of action is lacking. Two recent studies
provide important cell biological insights into the subcellular sites of NOD1- and NOD2-dependent signaling.The modern field of innate immunity is
centered on the study of several families
of pattern recognition receptors (PRRs).
These receptor families include the Toll-
like receptors (TLRs), NOD-like receptors
(NLRs), C-type lectin receptors (CLRs),
RIG-I-like receptors (RLRs), and AIM2-
like receptors (ALRs). Each of these
receptor families functions to detect mi-
crobial products in a multicellular host
and induces one or more antimicrobial re-
sponses that prevent infection. As such,
muchwork in this area has focused on un-
derstanding how PRRs detect microbial
products and the mechanisms of subse-
quent signal transduction. Despite being
one of the first PRR families discovered
(Philpott et al., 2014), insight into the
means by which NLRs detect their micro-
bial products lags far behind the other
families. Two recent studies have ad-
dressed these deficiencies in our knowl-
edge (Irving et al., 2014; Nakamura et al.,
2014), providing us with a much clearer
understanding of the earliest events asso-ciated with the activation of NLR-depen-
dent innate immune responses.
NLRs are a structurally related family of
proteins, with individual family members
serving distinct biological functions (Phil-
pott et al., 2014). For example, some
NLRs act as transcription factors in the
nucleus to promote the expression of
major histocompatibility complex (MHC)
genes, andothersact ascentral regulators
of inflammasome activation (Davis et al.,
2011). The assignment of NLRs as PRRs
came from studies of the NOD1 and
NOD2 proteins, which were found to acti-
vate NF-kB-dependent cytokine expres-
sion during infections with bacteria that
enter the cytosol. Reductionist studies
subsequently revealed that NOD1 and
NOD2 can be activated by specific com-
ponents of the bacterial cell wall, such
as d-glutamyl-meso-diaminopimelic acid
(iE-DAP) in the case ofNOD1 andmuramyl
dipeptide (MDP) in the case of NOD2 (Phil-
pott et al., 2014). Despite this knowledge,
several confusing aspects of NOD1 andNOD2 biology remained. For example, it
has been difficult to detect direct interac-
tions between these receptors and their
proposed ligands, whereas similar in-
quiries into receptor-ligand interactions
with other PRR families have been suc-
cessful. This issue has been further
complicated by the recent discovery that
some NLR family members do not bind
to microbial products directly, but rather
interact with upstream proteins of the
NAIP family that bind to specific microbial
ligands (Kofoed and Vance, 2011). These
findings raised the possibility that at least
some NLR family members are not actu-
ally PRRs, but are adaptor proteins that
facilitate the signaling functions of up-
stream PRRs. A second confusing aspect
of NLR biology has emerged from studies
demonstrating that natural NOD ligands
can trigger NF-kB activation when added
to the extracellular media of cultured cells
(Kaparakis et al., 2010). This finding was
surprising, since the NODs are cytosolic
proteins. Thus, it has long been suspected15, May 14, 2014 ª2014 Elsevier Inc. 523
